Background: The aim of this paper is to discuss the impact of COVID-19 on patients with urological malignancies (prostate cancer, bladder and upper tract urothelial cancer, kidney cancer, penile and testicular cancer) and to review the available recommendations reported in the literature. Methods: A review was performed, through the PubMed database, regarding available recommendations reported in the literature, to identify studies examining the impact of COVID-19 on treatment and clinical outcomes (including upstaging, recurrence, and mortality) for uro-oncological patients. Results: The COVID-19 pandemic dramatically changed the urological guidelines and patients’ access to screening programs and follow-up visits. Great efforts were undertaken to guarantee treatments to high-risk patients although follow up was not always possible due to recurrent surges, and patients with lower risk cancers had to wait for therapies. Conclusions: Physically and mentally, uro-oncological patients paid a heavy price during the COVID-19 pandemic. Long term data on the “costs” of clinical decisions made during the COVID-19 pandemic are still to be revealed and analyzed.

Gavi, F., Santoro, P. E., Amantea, C., Russo, P., Marino, F., Borrelli, I., Moscato, U., Foschi, N., Impact of COVID-19 on Uro-Oncological Patients: A Comprehensive Review of the Literature, <<MICROORGANISMS>>, 2023; 11 (1): 176-N/A. [doi:10.3390/microorganisms11010176] [https://hdl.handle.net/10807/223250]

Impact of COVID-19 on Uro-Oncological Patients: A Comprehensive Review of the Literature

Gavi, Filippo
Primo
;
Santoro, Paolo Emilio
Secondo
;
Amantea, Carlotta
;
Russo, Pierluigi;Marino, Filippo;Borrelli, Ivan;Moscato, Umberto
Penultimo
;
Foschi, Nazario
Ultimo
2023

Abstract

Background: The aim of this paper is to discuss the impact of COVID-19 on patients with urological malignancies (prostate cancer, bladder and upper tract urothelial cancer, kidney cancer, penile and testicular cancer) and to review the available recommendations reported in the literature. Methods: A review was performed, through the PubMed database, regarding available recommendations reported in the literature, to identify studies examining the impact of COVID-19 on treatment and clinical outcomes (including upstaging, recurrence, and mortality) for uro-oncological patients. Results: The COVID-19 pandemic dramatically changed the urological guidelines and patients’ access to screening programs and follow-up visits. Great efforts were undertaken to guarantee treatments to high-risk patients although follow up was not always possible due to recurrent surges, and patients with lower risk cancers had to wait for therapies. Conclusions: Physically and mentally, uro-oncological patients paid a heavy price during the COVID-19 pandemic. Long term data on the “costs” of clinical decisions made during the COVID-19 pandemic are still to be revealed and analyzed.
Inglese
Gavi, F., Santoro, P. E., Amantea, C., Russo, P., Marino, F., Borrelli, I., Moscato, U., Foschi, N., Impact of COVID-19 on Uro-Oncological Patients: A Comprehensive Review of the Literature, <<MICROORGANISMS>>, 2023; 11 (1): 176-N/A. [doi:10.3390/microorganisms11010176] [https://hdl.handle.net/10807/223250]
File in questo prodotto:
File Dimensione Formato  
microorganisms-11-00176.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 776.25 kB
Formato Adobe PDF
776.25 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/223250
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact